Abstract:Abstract The epithelial–mesenchymal transition (EMT) is an embryonic program frequently reactivated during cancer progression and is implicated in cancer invasion and metastasis. Cancer cells can also acquire stem cell properties to self-renew and give rise to new tumors through the EMT. Inactivation of the tumor suppressor PTEN has been shown to induce the EMT, but the underlying molecular mechanisms are less understood. In this study, we reconstituted PTEN-deficient breast cancer cells with wild-type and mutant PTEN, demonstrating that restoration of PTEN expression converted cancer cells with mesenchymal traits to an epithelial phenotype and inhibited cancer stem cell (CSC) activity. The protein rather than the lipid phosphatase activity of PTEN accounts for the reversal of the EMT. PTEN dephosphorylates and downregulates Abi1 in breast cancer cells. Gain- and loss-of-function analysis indicates that upregulation of Abi1 mediates PTEN loss-induced EMT and CSC activity. These results suggest that PTEN may suppress breast cancer invasion and metastasis via dephosphorylating and downregulating Abi1.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how PTEN exerts its tumor - suppressing role in breast cancer cells by inhibiting epithelial - mesenchymal transition (EMT) and cancer stem cell (CSC) activities. Specifically, the researchers want to understand the specific mechanism of PTEN protein phosphatase activity in this process and how it achieves these effects through dephosphorylation and down - regulation of Abi1. ### Background and Core Issues of the Paper 1. **EMT and Breast Cancer**: - Epithelial - mesenchymal transition (EMT) is a biological process in which epithelial cells lose their polarity and intercellular adhesion properties, acquire migratory and invasive abilities, and transform into mesenchymal cells. - EMT plays a crucial role in the development, invasion, and metastasis of breast cancer and is related to the generation of cancer stem cells (CSC), which have the ability of self - renewal and the ability to form new tumors. 2. **Functions of PTEN**: - PTEN is an important tumor - suppressor gene, and its functions include acting as a lipid phosphatase and a protein phosphatase. - The lipid phosphatase activity of PTEN counteracts the PI3K - Akt - mTOR signaling pathway by converting phosphatidylinositol (3,4,5) - trisphosphate (PIP3) to phosphatidylinositol 4,5 - bisphosphate (PIP2), thereby inhibiting cell proliferation, survival, and migration. - However, the role of PTEN's protein phosphatase activity in inhibiting EMT and CSC is not clear. ### Research Objectives - **Explore the role of PTEN's protein phosphatase activity in inhibiting EMT and CSC**: - By restoring PTEN expression, observe its effects on breast cancer cell morphology, EMT marker expression, and invasive ability. - By using different mutants of PTEN (G129E and C124S), distinguish the roles of PTEN's lipid phosphatase activity and protein phosphatase activity in inhibiting EMT and CSC. - **Identify PTEN's substrate Abi1**: - Through proteomic analysis, identify Abi1 as a new substrate of PTEN. - Explore the specific mechanism by which PTEN inhibits EMT and CSC through dephosphorylation and down - regulation of Abi1. ### Experimental Design and Results - **Restoring PTEN Expression**: - Re - expressing PTEN in PTEN - deficient breast cancer cells (such as BT549 cells), it was observed that the cells transformed from a mesenchymal phenotype to an epithelial phenotype, the expression of EMT - related markers was inhibited, and the invasive ability of the cells was reduced. - **PTEN Mutant Experiments**: - Experiments were carried out using PTEN's G129E mutant (retaining protein phosphatase activity but losing lipid phosphatase activity) and C124S mutant (losing both protein and lipid phosphatase activities). - The results showed that only the G129E mutant retaining protein phosphatase activity was able to restore the epithelial phenotype and inhibit EMT and CSC activities. - **The Role of Abi1**: - Abi1 was identified as a substrate of PTEN. PTEN causes the degradation of Abi1 by dephosphorylating the Y213 and S216 sites of Abi1. - In PTEN - deficient breast cancer cells, the expression of Abi1 was significantly up - regulated. - Over - expressing Abi1 induces an increase in EMT and CSC activities in normal breast epithelial cells (such as MCF10A cells). - Knocking down Abi1 partially reversed EMT and CSC activities in PTEN - deficient breast cancer cells. ### Conclusion This study reveals that PTEN inhibits EMT and CSC activities in breast cancer cells through dephosphorylation and down - regulation of Abi1 by its protein phosphatase activity, providing a new molecular mechanism to explain PTEN's tumor - suppressing role in breast cancer. These findings may provide new targets for the development of novel treatment strategies for breast cancer metastasis and recurrence.

PTEN suppresses epithelial–mesenchymal transition and cancer stem cell activity by downregulating Abi1